3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
5
Urogenital Neoplasms
1
Prostatic Neoplasms, Castration-Resistant
1
Prostatic Diseases
1
Neoplasms by Site
1
Neoplasms
1
Neoplasm Metastasis
1
Neoadjuvant Therapy
1
Genital Neoplasms, Male
1
Genital Diseases, Male
1
Castration-resistant Prostate Cancer
1
Interventions
pembrolizumab
1
enzalutamide
1
abiraterone
1
Radium-223
1
Carboplatin
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Castration-resistant Prostate Cancer
×
abiraterone
×
Clear all
NCT04839055
2021-04-09
CoA-CRPC
Jiangnan University
Phase 1/2
Unknown
50 enrolled